Cargando…
Drug-induced liver disease /
This field has shown tremendous growth in recent years, primarily due to the recognition that drug-induced liver disease is the most common cause of liver failure and one of the major contributors to the withdrawal of drugs developed by the pharmaceutical industry. Drug-Induced Liver Disease, 3rd ed...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
Academic,
2013.
|
| Edición: | 3rd ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn841488683 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130502s2013 enka ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d OCLCO |d N$T |d CDX |d YDXCP |d GGVRL |d OCLCQ |d USU |d OCLCO |d ICA |d OCLCA |d OCLCF |d OCLCO |d CASUM |d OCLCO |d LVT |d OCLCO |d OCLCQ |d AGLDB |d MERER |d OCLCQ |d U3W |d D6H |d OCLCQ |d VTS |d COCUF |d AU@ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d STF |d LEAUB |d AJS |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCL | ||
| 020 | |a 9780123878182 |q (electronic bk.) | ||
| 020 | |a 0123878187 |q (electronic bk.) | ||
| 020 | |z 9780123878175 | ||
| 020 | |z 0123878179 | ||
| 029 | 1 | |a AU@ |b 000051280517 | |
| 029 | 1 | |a DEBBG |b BV042318162 | |
| 029 | 1 | |a DEBSZ |b 405348169 | |
| 029 | 1 | |a DEBSZ |b 481272828 | |
| 029 | 1 | |a NZ1 |b 15194382 | |
| 035 | |a (OCoLC)841488683 | ||
| 050 | 4 | |a RC848.H48 |b D78 2013 | |
| 060 | 4 | |a WI 700 |b D7943 2013 | |
| 072 | 7 | |a MED |x 114000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.362 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Drug-induced liver disease / |c [edited by] Neil Kaplowitz, MD, Professor of Medicine and Director, Research Center for Liver Diseases, Chief, Division of GI-Liver, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA, Laurie D. DeLeve, MD, PhD, Professor of Medicine, Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. |
| 250 | |a 3rd ed. | ||
| 260 | |a Oxford : |b Academic, |c 2013. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Previous edition: 2008. | ||
| 520 | |a This field has shown tremendous growth in recent years, primarily due to the recognition that drug-induced liver disease is the most common cause of liver failure and one of the major contributors to the withdrawal of drugs developed by the pharmaceutical industry. Drug-Induced Liver Disease, 3rd edition is a comprehensive reference that covers mechanisms of injury, diagnosis and management, major hepatotoxins, regulatory perspectives and much more. Written by highly respected authorities, this new edition is an updated and definitive reference for clinicians and scientists in academia, the pharmaceutical industry and government settings. This book contains 4 new chapters on key topics in the area and provides a current and extensive review of the latest developments concerning the toxicology, pharmacology, genetics and immunology of drug-induced liver disease. A multi-authored reference work written by leading clinical, academic and industry experts in drug-induced liver disease. Contains four new chapters on key areas in the field, including one on worldwide drug-induced liver injury networks. Each chapter has been updated to address the latest research and findings in the field and 16 new chapter authors have been added to this new edition. Includes coverage of the basic, clinical and practical aspects of drug-induced liver disease to provide the single most comprehensive reference on the subject. | ||
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a I. Mechanisms of liver injury -- II. Diagnosis and management -- III. Hepatotoxicity of specific drugs -- IV. Future directions. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Hepatotoxicology. | |
| 650 | 0 | |a Liver |x Effect of drugs on. | |
| 650 | 0 | |a Drugs |x Side effects. | |
| 650 | 0 | |a Toxic hepatitis. | |
| 650 | 1 | 2 | |a Chemical and Drug Induced Liver Injury |
| 650 | 2 | 2 | |a Liver |x drug effects |
| 650 | 2 | 2 | |a Drug-Related Side Effects and Adverse Reactions |
| 650 | 6 | |a Hépatotoxicité. | |
| 650 | 6 | |a Foie |x Effets des médicaments sur. | |
| 650 | 6 | |a Médicaments |x Effets secondaires. | |
| 650 | 6 | |a Hépatite toxique. | |
| 650 | 7 | |a MEDICAL |x Hepatology. |2 bisacsh | |
| 650 | 7 | |a Toxic hepatitis |2 fast | |
| 650 | 7 | |a Drugs |x Side effects |2 fast | |
| 650 | 7 | |a Hepatotoxicology |2 fast | |
| 650 | 7 | |a Liver |x Effect of drugs on |2 fast | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Kaplowitz, Neil. | |
| 700 | 1 | |a DeLeve, Laurie D., |d 1955- |1 https://id.oclc.org/worldcat/entity/E39PCjr6FYqmctHJKpYWrVT6Xd | |
| 758 | |i has work: |a Drug-induced liver disease (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFPJpq3yKwDp6MqjwGKwFq |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Drug-induced liver disease. |b Third edition |z 9780123878175 |w (DLC) 2013372236 |w (OCoLC)827266699 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1173868 |z Texto completo |
| 938 | |a Coutts Information Services |b COUT |n 25389946 | ||
| 938 | |a EBSCOhost |b EBSC |n 485994 | ||
| 938 | |a Cengage Learning |b GVRL |n GVRL8DNW | ||
| 938 | |a YBP Library Services |b YANK |n 10585088 | ||
| 994 | |a 92 |b IZTAP | ||